PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Neuronal Cell Signaling, EBRI Rita Levi-Montalcini Foundation, Rome 00161, Italy.\', \'Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj 66177-13446, Iran.\', \'Department of Chemistry and National Inter-University Consortium for Materials Science and Technology-INSTM-UdR Milano, University of Milan, Milan 20133, Italy.\', \'Institute of Science and Chemical Technology \'Giulio Natta\', Milan 20133, Italy.\', \'Human Physiology Lab, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.\', \'Department of Neurorehabilitation Sciences, Casa di Cura del Policlinico, Milan 20144, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acschemneuro.0c00373
?:doi
?:hasPublicationType
?:journal
  • ACS chemical neuroscience
is ?:pmid of
?:pmid
?:pmid
  • 32627524
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.442
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Considerations around the SARS-CoV-2 Spike Protein with Particular Attention to COVID-19 Brain Infection and Neurological Symptoms.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all